|
Match
|
Document |
Document Title |
|
|
US20090291145 |
MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES
A method is provided that includes using an antisense approach to reverse and/or delay an autoimmune diabetes condition in vivo. The oligonucleotides are targeted to bind to primary transcripts...
|
|
|
US20090285904 |
ENHANCED ANTIMICROBIAL ACTIVITY OF PLANT ESSENTIAL OILS
Antimicrobial compositions based on a combination of plant essential oils of enhanced antimicrobial effectiveness are prepared by adding to the combination of at least two plant essential oils, a...
|
|
|
US20090280176 |
CONTROLLED RELEASE FORMULATIONS OF ALPRAZOLAM
A controlled release formulation of alprazolam for once a day administration to a mammalian subject, which formulation releases alprazolam along a pre-determined release profile, is provided.
|
|
|
US20090274765 |
Compositions and Methods for Drug Delivery
The present disclosure is directed to surface-modified particles and to methods of making and using the same. The surface-modified particles comprise a particle core and a coating associated with...
|
|
|
US20090274752 |
COSMETIC AND DERMATOLOGICAL FORMULATIONS OF MNTF PEPTIDES
The disclosure is directed to methods and compositions that include MNTF peptides and their analogs for cosmetic and dermatological purposes.
|
|
|
US20090269412 |
Pharmaceutical formulations for dry powder inhalers
A powder for use in a dry powder inhaler comprises: i) a fraction of fine particle size constituted by a mixture of physiologically acceptable excipient and an additive; ii) a fraction of coarse...
|
|
|
US20090269411 |
MASKING THE TASTE OF POWDERS
Taste-masked powders that can be inhaled or administered orally, a simple method for the production thereof, and the use thereof for applying biologically active substances.
|
|
|
US20090269400 |
Nanoparticulate and Controlled Release Compositions Comprising a Cephalosporin
The present invention is directed to compositions comprising a nanoparticulate antibiotic having improved bioavailability. Preferably, the antibiotic comprises nanoparticulate cephalosporin...
|
|
|
US20090269395 |
USE OF PROTOBERBERINES AS AN ACTIVE SUBSTANCE REGULATING THE PILOSEBACEOUS UNIT
The present invention relates to cosmetic use, by topic application on the skin of at least one protoberberine, with exception of berberine, or a vegetable extract containing it, as an active...
|
|
|
US20090263490 |
Microsphere beeswax for mammalian dietary fat mitigation
A device composed of a plurality of beeswax microspheres are contained within a digestible capsule intended for the alimentary tract of the mammal. A method in which the device is ingested orally...
|
|
|
US20090263489 |
ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS AND METHODS FOR REDUCING, PREVENTING OR TREATING PAIN AND INFLAMMATION
Effective treatments of acute pain and/or inflammation for extended periods of time are provided. Through the administration of an effective amount of sulfasalazine at or near a target site, one...
|
|
|
US20090263479 |
FORMULATIONS FOR POORLY PERMEABLE ACTIVE PHARMACEUTICAL INGREDIENTS
The present invention relates to a pharmaceutical oral dosage form containing a poorly permeable active pharmaceutical ingredient and at least one permeability improving substance, wherein the...
|
|
|
US20090263443 |
METHODS FOR TREATING POST-OPERATIVE EFFECTS SUCH AS SPASTICITY AND SHIVERING WITH CLONDINE
Effective treatments of spasticity and shivering that accompanies surgeries are provided. Through the administration of an effective amount of clonidine at or near a target site, one can relax...
|
|
|
US20090258088 |
USE OF MATERIALS AND EXTERNAL STIMULI FOR SYNOVECTOMY
This invention has as one of its aspects a method to provide a safe an effective treatment for synovectomy. The method involves the administration a material to the affected joint, allowing the...
|
|
|
US20090258075 |
Respiratory Drug Condensation Aerosols and Methods of Making and Using Them
Described herein are respiratory drug condensation aerosols and methods of making and using them. Kits for delivering condensation aerosols are also described. The respiratory drug aerosols...
|
|
|
US20090258074 |
MIXTURES OF TANNINS, THEIR PRODUCTION AND USE IN MEDICAMENTS OR AS DISINFECTANTS
The invention relates to a mixture comprising
i) at least one condensation product (A) obtainable by reaction of
a1) at least one aromatic system or heteroaromatic system, a2) at least one...
|
|
|
US20090258073 |
MAGNETIC CARRIER AND MEDICAL PREPARATION FOR CONTROLLABLE DELIVERY AND RELEASE OF ACTIVE SUBSTANCES, METHODS OF THEIR PRODUCTION AND METHODS OF TREATMENT USING THEREOF
The present invention relates to magnetic carriers and medical preparations for controllable delivery and release of active substances. The carrier for active substances comprises material A, which...
|
|
|
US20090258046 |
COMPOSITION, FORMULATIONS AND KIT FOR TREATMENT OF RESPIRATORY AND LUNG DISEASE WITH NON-GLUCOCORTICOID STEROIDS AND/OR UBIQUINONE AND A BRONCHODILATING AGENT
A pharmaceutical or veterinary composition, which comprises a first active agent selected from a non-glucocorticoid steroid or analogues, a ubiquinone, or salts thereof, and a second active agent...
|
|
|
US20090252806 |
NANOPARTICULATE TACROLIMUS FORMULATIONS
The present invention is directed to nanoparticulate tacrolimus compositions. The composition comprising tacrolimus particles having an effective average particle size of less than about 2000 nm...
|
|
|
US20090252805 |
Film-Coated and/or Granulated Calcium-Containing Compounds and Use Thereof in Pharmaceutical Compositions
Calcium-containing compounds have been at least partly film-coated and/or granulated with a water-soluble substance and a water-soluble polymeric substance and use of such coated compounds in...
|
|
|
US20090252796 |
NUTRITIONAL SUPPLEMENT FOR THE PREVENTION OF CARDIOVASCULAR DISEASE, ALZHEIMER'S DISEASE, DIABETES, AND REGULATION AND REDUCTION OF BLOOD SUGAR AND INSULIN RESISTANCE
A mixture (which may be utilized as a food or a drink or a supplement or a drug or a cosmetic or a hygienic product) that is formulated and is capable of improving a person's well being, lowering...
|
|
|
US20090252787 |
GRANULAR PHARMACEUTICAL COMPOSITIONS
Pharmaceutical compositions comprising a plurality of formulated particles containing at least one active ingredient and at least one pharmaceutically acceptable excipient, granulated with a...
|
|
|
US20090246285 |
MONODISPERSED ORGANIC MONOLAYER COATED CALCIUM-CONTAINING NANOPARTICLES
A method for the synthesis of monodispersed, organic-monolayer coated, calcium-containing nanoparticles is presented. A biphasic liquid system comprises an aqueous phase of bare particles and an...
|
|
|
US20090246275 |
Compositions and methods for delivery of embolics
Described herein are compositions comprising one or more embolics attached to an inert, dissolvable matrix as well as kits comprising these novel embolic formulations. Also described are methods of...
|
|
|
US20090246256 |
Compositions and Methods for Transmucosal Delivery of Lofexidine
The present invention provides for compositions and methods for accelerating the rate of delivery of lofexidine to the systemic circulation by transmucosal administration through the nasal,...
|
|
|
US20090238884 |
COMPOSITIONS FOR SITE-SPECIFIC DELIVERY OF IMATINIB AND METHODS OF USE
The invention provides an oral formulation for administering to a subject comprising an imatinib compound and an enteric matrix or enteric coating or a combination thereof, whereby at least 80% of...
|
|
|
US20090238883 |
LIVER-SPECIFIC NANOCAPSULES AND METHODS OF USING
This disclosure describes liver-specific nanocapsules for specifically targeting liver cells. This disclosure also provides methods of using such liver-specific nanocapsules to deliver one or more...
|
|
|
US20090238867 |
Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
Nanoparticulate compositions comprising anidulafungin are described, as well as methods of making such compositions. Also described are methods for treatment of fungal infections.
|
|
|
US20090232897 |
PHARMACEUTICAL COMPOSITIONS COMPRISING CONJUGATED ESTROGENS
Pre-mix compositions containing conjugated estrogens and a pharmaceutical carrier, and pharmaceutical formulations containing a pre-mix composition. Further, the invention includes processes for...
|
|
|
US20090232896 |
Use of Magnesium Stearate Dihydrate for Lubrication of Solid Pharmaceutical Compositions
The invention provides lubricant compositions comprising magnesium stearate dihydrate. The lubricant compositions may be used to lubricate a variety of bioactive formulations including...
|
|
|
US20090226530 |
POWDERED PROTEIN COMPOSITIONS AND METHODS OF MAKING SAME
A method for preparing a protein or peptide powder is provided that includes spray drying a solution including more than, e.g., about 50 mg/mL of a protein or peptide (e.g., an antibody or antigen...
|
|
|
US20090226528 |
ENCAPSULATED NANOPARTICLES FOR NUCLEIC ACID DELIVERY
Methods and compositions for delivering agents (e.g., gene silencing agents) and molecules to cells using yeast cell wall particles are presented herein. Embodiments of the invention are...
|
|
|
US20090220591 |
Pharmaceutical Compositions Comprising Non-Steroidal Antiinflammatory Drug, Antipyretic-Analgesic Drug and Proton Pump Inhibotor
The present invention relates to pharmaceutical compositions in the form of fixed combination comprising non-steroidal anti-inflammatory drug or its single enantiomers or salts thereof,...
|
|
|
US20090214665 |
Controlled Release Muscarinic Receptor Antagonist Formulation
An oral controlled release pharmaceutical composition for muscarinic receptor antagonist, preferably tolterodine, that employs a drug core, a rapidly disintegrating or rapidly dissolving coating...
|
|
|
US20090214661 |
PROCESS FOR THE PRODUCTION OF BEADLETS
A process for the production of cross-linked beadlets containing one or more active ingredients selected from the group of a fat-soluble vitamin active material, a carotenoid and a polyunsaturated...
|
|
|
US20090214660 |
ENCAPSULATION SYSTEM
The present invention is directed to a composition comprising high mannuronic acid-containing alginate and a polycation having a polydispersity index of less than 1.5. The composition is...
|
|
|
US20090214647 |
Compositions For Enternal Application Of Microorganisms
The present invention describes a process for the manufacture of a solid composition comprising a microorganism, which process comprises a first step of blending and/or compacting the microorganism...
|
|
|
US20090214645 |
PHARMACEUTICAL COMPOSITIONS COMPRISING A PH-DEPENDENT DRUG, A PH MODIFIER AND A RETARDING AGENT
The present invention concerns pharmaceutical compositions comprising a pH-dependent drug compound and a pH modifier.
|
|
|
US20090214618 |
Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
The presently disclosed subject matter relates to nitric oxide-releasing particles for delivering nitric oxide, and their use in biomedical and pharmaceutical applications.
|
|
|
US20090208583 |
TABLETS COMPRISING CANDESARTAN CILEXETIL
Composition in the form of a tablet, comprising candesartan cilexetil and optionally further active agents and usual adjuncts, wherein the surface of at least the active agent candesartan cilexetil...
|
|
|
US20090208566 |
Capsules Containing Seminal Material for Artificial Insemination
Capsules or microcapsules comprising: a) a nucleus containing seminal material or the spermatozoa of animal species chosen from the group consisting of equids, buffalo, ovicaprids, canids, felids,...
|
|
|
US20090202651 |
Antigen specific fluorescent nanoparticles
The present invention relates, in general, to nanoparticles and, in particular, to nanoparticles coated with, for example, peptides, proteins, and/or carbohydrates, and to methods of producing and...
|
|
|
US20090202649 |
FENOFIBRATE FORMULATIONS
The present invention relates to pharmaceutical formulations comprising fenofibrate. The invention also relates to stable and bioavailable pharmaceutical formulations comprising fenofibrate....
|
|
|
US20090196935 |
Pharmaceutical Capsules Comprising Extended Release Dipyridamole Pellets
The present invention is directed to pharmaceutical capsules comprising extended release formulations of dipyridamole, processes for preparing such dipyridamole extended release formulations and...
|
|
|
US20090196827 |
Drug Loaded Contrast Agents: Combining Diagnosis and Therapy
This invention provides an improvement to methods of drug loading of ultrasound contrast agents. Echogenic drug-loaded polymer microcapsules, nanocapsules, or mixtures thereof produced by the...
|
|
|
US20090191274 |
Pharmaceutical composition of amlodipine maleate having enhanced stability
The present invention relates to a coated particle of amlodipine maleate and a pharmaceutical composition for cardiovascular disease (CVD) comprising the coated particle of amlodipine maleate. The...
|
|
|
US20090191267 |
Oral Compositions Containing a Salivation Inducing Agent
Oral dosage forms, and particles used therein, containing salivation inducing agents are disclosed. The salivation agents may be in the core of the dosage form and/or in coatings applied thereto,...
|
|
|
US20090191245 |
REDUCED-IRRITANT DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE NAPHTHOIC ACID COMPOUND AND BENZOYL PEROXIDE AND TREATMENT OF KERATINIZATION DISORDERS THEREWITH
Topically applicable, reduced-irritant dermatological/cosmetic compositions useful for the prevention/treatment of a variety of keratinization disorders, for example acne vulgaris, contain at least...
|
|
|
US20090191128 |
CORE-SHELL NANOPARTICLES FOR THEARAPY AND IMAGING PURPOSES
The invention relates to nanoparticles coated with an inorganic nanoscale material herein referred to as core-shell nanoparticle, in which the core material has a wider band gap than the shell...
|
|
|
US20090181076 |
Drug Release From Nanoparticle-Coated Capsules
Methods of producing a controlled release formulation for an active substance are disclosed, wherein the methods involve dispersing a discontinuous phase comprising an active substance into a...
|